Status:
COMPLETED
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
Lead Sponsor:
Centre Hospitalier de Bligny
Conditions:
COPD
Dyspnea
Eligibility:
All Genders
30-90 years
Phase:
NA
Brief Summary
Patients with chronic obstructive pulmonary disease (COPD) are prone to breathlessness, chest tightness and other anxiety-inducing symptoms. Medical therapy for the condition focus on improving these ...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent and debilitating respiratory condition characterized by chronic airflow limitation, increased respiratory rate, dyspnea and other per...
Eligibility Criteria
Inclusion
- Aged \> 30.
- Affiliated to a Social Security scheme or beneficiary of such a scheme.
- Absence of cognitive disease questioning the validity of patient reported outcomes
- Ability to give free, informed consent.
- Adult patients with severe COPD, dyspnea ; with distension.
- Hospitalized at the CHB.
- Predicted FEV1 and FEV/FVC percentages consistent with severe COPD according to GOLD standards.
- Modified Research Council Questionnaire ≥2
- Exposure to tobbacco \>= 10 packs/yrs.
Exclusion
- Pregnancy
- Known severe cardiac insufficiency.
- Known severe pulmonary arterial hypertension.
- Evolutive-cancer diagnosis.
- Significant cognitive impairment, hypercapnic encephalopathy or confusional syndrome.
- Deafness.
- Anemia ≤ 8g/dL.
- Psychotic pathology.
Key Trial Info
Start Date :
September 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 19 2024
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT04868357
Start Date
September 27 2021
End Date
April 19 2024
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Bligny
Briis-sous-Forges, Briis-sous-Forges, France, France